REPL::Rights::Voluntary

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Security
BIOLIDICS LIMITED - SGXE89830751 - 8YY

Announcement Details

Announcement Title
Lodgement of Offer Information Statement (OIS)
Date &Time of Broadcast
08-Nov-2022 18:24:49
Status
Replacement
Corporate Action Reference
SG220929RHDID55B
Submitted By (Co./ Ind. Name)
Song Tang Yih
Designation
Executive Director and Chief Executive Officer
Event Status
Pending Record Date Processing
Underwritten
No
Shareholders' Approval Required?
No
Shareholders' Approval Obtained
No
Financial Year End
31/12/2022
Foreign Shareholder Eligibility
No
Attachment for Intent
Revision of Terms of Rights Issue.pdf

Event Narrative

Narrative Type
Narrative Text
Additional TextPROPOSED RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE - REVISION OF ISSUE PRICE

Dates

Record Date and Time
08/11/2022 17:00:00
Ex Date
07/11/2022

Rights Details

Rights Security ISIN
SGXN44615593
Rights Security Name
BIOLIDICS LIMITED R
Security Not Found?
No
Renounceable
Yes
Trading Period From
11/11/2022
Trading Period To
21/11/2022
Rights Security Distribution Ratio- Underlying
1
Rights Security Distribution Ratio- Rights Security
1

Offer Information Statement

Offer Information Statement Lodged?
Yes
Attachment for OIS
Offer Information Statement.pdf
Announcement on OIS Lodgement.pdf

Option Exercise

Issue Price (Per Rights)
SGD 0.025
Exercise Period
11/11/2022 TO 25/11/2022
Disbursed Security
ISIN
Name
Security Type
Distribution Ratio- Rights
Distribution Ratio- Disbursed
SGXE89830751BIOLIDICS LIMITEDOrdinary Share11

Renounceable Conditions

Allow Over Subscription
Yes

Attachments

Related Announcements